Safety and patient response as indicated by biomarker changes to binding immunoglobulin protein in the phase I/IIA RAGULA clinical trial in rheumatoid arthritis
RAGULA I/IIA期临床试验中类风湿性关节炎患者的安全性和患者反应,以结合免疫球蛋白蛋白的生物标志物变化为指标
期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/kew287
Kirkham, Bruce; Chaabo, Khaldoun; Hall, Christopher; Garrood, Toby; Mant, Timothy; Allen, Elizabeth; Vincent, Alexandra; Vasconcelos, Joana C; Prevost, Andrew T; Panayi, Gabriel S; Corrigall, Valerie M